• OPEN AN ACCOUNT
Indian Indices
Sensex
74,785.42 -73.57
( -0.10%)
Global Indices
Nasdaq
52,073.35 369.71
(0.72%)
Dow Jones
7,785.28 113.78
(1.48%)
Hang Seng
65,040.24 903.99
(1.41%)
Nikkei 225
10,737.46 78.33
(0.73%)
Forex
USD-INR
95.99 0.12
(0.12%)
EUR-INR
110.24 0.24
(0.22%)
GBP-INR
128.54 0.36
(0.28%)
JPY-INR
0.61 0.00
(-0.53%)

EQUITY - MARKET SCREENER

Salora International Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
500370
INE924A01013
57.8784336
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SALORAINTL
0
23.38
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Anthem Biosciences consolidated net profit rises 129.68% in the March 2026 quarter
May 20,2026
Net profit of Anthem Biosciences rose 129.68% to Rs 189.76 crore in the quarter ended March 2026 as against Rs 82.62 crore during the previous quarter ended March 2025. Sales rose 26.44% to Rs 610.94 crore in the quarter ended March 2026 as against Rs 483.20 crore during the previous quarter ended March 2025.

For the full year,net profit rose 31.14% to Rs 591.79 crore in the year ended March 2026 as against Rs 451.26 crore during the previous year ended March 2025. Sales rose 15.17% to Rs 2124.33 crore in the year ended March 2026 as against Rs 1844.55 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales610.94483.20 26 2124.331844.55 15
OPM %43.7440.40 -39.2536.37 -
PBDT316.53208.73 52 982.70746.24 32
PBT276.94178.31 55 848.63656.87 29
NP189.7682.62 130 591.79451.26 31